Rosacea and the gut–skin axis: what's known, what's hype, and what to do

The “gut–skin axis” is one of the most-discussed and least-precise topics in rosacea media. People with rosacea hear claims about leaky gut, candida overgrowth, dysbiosis, restrictive elimination diets, and probiotic supplements — many of them framed with more confidence than the underlying evidence supports. The Canadian Clinical Practice Guidelines for Rosacea, co-authored by Dr. Jason Rivers, acknowledge possible gastrointestinal associations with rosacea but caution that targeted therapies for them are not yet established as routine rosacea care (Asai et al. 2016, J Cutan Med Surg, PMID 27207355).

This guide separates what the studies actually show from what the marketing copy implies — and identifies low-risk steps that won’t backfire on sensitive skin.

What “gut–skin axis” actually means

The gut–skin axis is the proposition that conditions of the gastrointestinal tract — its bacterial composition, its barrier integrity, its inflammatory tone — can influence the skin and vice versa. The mechanisms proposed include systemic low-grade inflammation, changes to circulating bile acids and short-chain fatty acids, immune cell trafficking, and the indirect effect of GI symptoms on stress and sleep, both of which independently affect rosacea (Mar & Rivers 2023, J Cutan Med Surg, PMID 37898903).

The most-discussed observations in rosacea specifically are an increased rate of small intestinal bacterial overgrowth (SIBO), a higher prevalence of Helicobacter pylori infection, and an association with inflammatory bowel disease (IBD).

What the evidence shows — three bodies of work

Small intestinal bacterial overgrowth (SIBO)

The single most cited paper is Parodi and colleagues 2008, a study of 113 patients with rosacea and 60 controls. SIBO prevalence was substantially higher in the rosacea group than controls (about 46% versus 5%), and patients who received rifaximin to eradicate SIBO had a marked improvement in cutaneous lesions, sustained at nine months (Parodi et al. 2008, Clin Gastroenterol Hepatol, PMID 18456568). A 2013 follow-up by the same group reported similar findings on a larger cohort, and a three-year extension found durable improvement after eradication.

That’s a striking result, but several caveats apply. The cohorts were Italian and ascertained through dermatology clinics, which may not generalise to all populations. The breath tests used to diagnose SIBO have known false-positive and false-negative rates. And not every replication has produced the same magnitude of association. The Cochrane systematic review of rosacea interventions did not find sufficient evidence to recommend SIBO eradication as routine rosacea care, even while noting the consistent signal across small studies (van Zuuren et al. 2019, Br J Dermatol, PMID 30585305).

The honest summary: SIBO appears more common in some rosacea populations than in matched controls, and treatment of confirmed SIBO appears to help skin in those individuals. SIBO is not present in every rosacea patient, and empirical antibiotic therapy without diagnostic confirmation is not recommended.

Helicobacter pylori

H. pylori — the gastric bacterium famously implicated in peptic ulcers — has been investigated in rosacea for over two decades. Some studies show a higher seroprevalence in rosacea patients; others show no meaningful difference. Meta-analyses have produced mixed signals, with effect sizes that fluctuate based on the populations studied and the diagnostic method used (serology versus stool antigen versus breath testing).

Critically, H. pylori prevalence varies dramatically by geography and age. In populations with high background prevalence, finding elevated rates in rosacea patients is harder to interpret causally. The 2017 ROSCO consensus on rosacea diagnosis and classification did not endorse routine H. pylori testing in rosacea management (Tan et al. 2017, Br J Dermatol, PMID 27718519).

For someone who has a separate medical indication to test for H. pylori — dyspepsia, history of ulcer disease — that workup makes sense on its own merits, and treatment may incidentally help rosacea. Testing purely as a rosacea workup is not currently standard.

Inflammatory bowel disease (IBD)

The IBD–rosacea association is among the more reproducible. A large nationwide Danish cohort study of nearly 50,000 rosacea patients found increased incidence of Crohn disease, ulcerative colitis, coeliac disease, H. pylori infection, SIBO, and irritable bowel syndrome compared with controls (Egeberg et al. 2017, Br J Dermatol, PMID 27501017). The absolute risks remain small for any individual patient — most people with rosacea do not have IBD — but the relative-risk signal is consistent across multiple populations.

This doesn’t mean rosacea causes IBD or vice versa. It likely reflects shared genetic and immunological mechanisms (innate immune dysregulation, cathelicidin / LL-37 pathways, vascular dysfunction). For an individual with rosacea, the practical implication is small: be alert to GI symptoms — persistent diarrhoea, blood in stool, unintentional weight loss, abdominal pain — that warrant separate medical workup, rather than dismissing them as unrelated.

What “the microbiome” doesn’t tell you

Direct-to-consumer microbiome tests, marketed as ways to “fix your rosacea from the inside out,” currently outpace the evidence. The cutaneous microbiome and the gut microbiome are both biologically real and clinically interesting, but the leap from a 16S rRNA sequencing report to a treatment plan is mostly speculative for rosacea today. The 2017 update to the National Rosacea Society’s standard classification did not include microbiome-based interventions in evidence-based rosacea management (Gallo et al. 2018, J Am Acad Dermatol, PMID 29089180).

That doesn’t mean microbiome research is uninteresting — it’s an active area. It does mean that paying for a stool test and a custom probiotic regimen on the basis of rosacea alone is not currently evidence-supported.

Low-risk habits worth trying

What can you do today, knowing what we know? A short list of changes that are unlikely to backfire and that have either modest direct evidence or strong rationale on adjacent grounds:

Track GI symptoms alongside skin. A simple journal noting bowel habits, bloating, and skin status across two to four weeks often reveals patterns. If GI symptoms are chronic, see a primary-care clinician or gastroenterologist regardless of the skin question.

Eat the standard “boring” healthy diet. A whole-food, fibre-forward diet with adequate fermented foods (yogurt, kefir, kimchi, sauerkraut as tolerated) is generally well evidenced for general gut health and is unlikely to harm skin. Highly restrictive elimination diets — keto, carnivore, prolonged FODMAP exclusion — can sometimes help GI-driven skin patterns short-term but are not maintenance plans.

Limit known direct flushing triggers. Hot drinks, alcohol, and very spicy food are the rosacea-specific culprits — these act on neurogenic flushing pathways including TRPV1 (Steinhoff et al. 2011, J Investig Dermatol Symp Proc, PMID 22076321) — not on the gut microbiome per se.

Manage stress. Chronic stress has documented effects on the gut–brain–skin axis and on rosacea flares directly (Mar & Rivers 2023, PMID 37898903). Sleep, exercise, and stress-management aren’t trendy advice; they’re well-supported adjuncts.

Be cautious with probiotic supplements. A general-purpose probiotic is unlikely to cause harm and may help some people. Megadose, condition-specific, “rosacea-targeted” probiotics with proprietary blends and aggressive pricing are not evidence-supported as of 2026.

For other foundations that do have strong evidence — gentle barrier-supportive skincare, daily sun protection, and trigger management — see a gentle routine for redness-prone skin, mineral sunscreen for rosacea, and common skincare irritants for rosacea. For prescription and procedural options when topicals plus lifestyle aren’t enough, see our rosacea treatment pillar.

When to see a clinician

A few patterns deserve evaluation rather than self-management:

Persistent GI symptoms — chronic diarrhoea, recurrent constipation, blood in stool, unintentional weight loss, severe bloating — should be discussed with a primary-care doctor or gastroenterologist independent of the skin question.

A clear time-locked relationship between a specific food or drink and skin flares is worth investigating with a clinician rather than guessing — true food hypersensitivity is rare in rosacea, but adjacent conditions (mast-cell activation, true food allergy) sometimes get conflated with rosacea triggers.

Worsening rosacea despite consistent skincare and trigger management is itself a reason to be evaluated. Topical and oral prescription options — and procedural treatments for vascular components — exist precisely for this case (van Zuuren et al. 2019, PMID 30585305).

Frequently asked questions

Should I be tested for SIBO if I have rosacea?

Not as a routine rosacea workup. If you have GI symptoms — persistent bloating, alternating diarrhoea and constipation, postprandial discomfort — that warrant SIBO testing on their own merits, the testing makes sense and a positive result is worth treating. Empirical antibiotic therapy without testing isn’t currently recommended.

Will treating H. pylori cure my rosacea?

For a small subset of patients with both, eradication has been associated with rosacea improvement. For most patients, no clear-cut benefit is shown. The 2017 ROSCO consensus doesn’t endorse routine H. pylori testing for rosacea (Tan et al. 2017, PMID 27718519). If you’re being tested for separate GI reasons, that’s a reasonable workup; if not, it’s not currently standard.

Are probiotics evidence-based for rosacea?

The evidence is preliminary. A few small studies suggest specific probiotic strains may help some patients, but no consensus regimen exists. A standard yogurt or kefir as part of a balanced diet is reasonable; expensive condition-specific blends with strong claims are not currently supported.

Does a low-FODMAP or gluten-free diet help rosacea?

Not as routine advice. If you have coeliac disease, IBS-D, or documented food intolerances driving GI symptoms, treating those may indirectly help skin via stress, sleep, and inflammation. Restrictive diets pursued specifically to “cure rosacea” rarely deliver and risk nutritional gaps.

What about leaky gut syndrome?

“Leaky gut” is a colloquial term for increased intestinal permeability. The phenomenon is real in some pathological contexts (severe IBD, coeliac disease, sepsis), but the marketed concept of generalised leaky gut driving rosacea is not currently evidence-based. Routine “leaky gut” panels marketed direct-to-consumer are not validated.

Is alcohol a gut trigger or a skin trigger for rosacea?

Both, by different mechanisms. Direct cutaneous flushing happens via vasodilation and TRPV1 activation. Alcohol is also irritating to the gut lining and can worsen GI inflammation in IBD or IBS. For most people with rosacea, the direct flushing effect is what they notice within minutes; the gut effect is slower and easier to miss.

Should I take a stool microbiome test?

Direct-to-consumer microbiome testing for rosacea is not currently evidence-based. The reports are interesting but rarely actionable, and the recommendations that come with them often outrun the science.

How long after fixing my gut might my skin improve?

If a real GI driver exists and is treated, skin improvement is often gradual over weeks to months. The Parodi SIBO study showed sustained skin improvement at nine months after rifaximin treatment in confirmed-SIBO patients (Parodi et al. 2008, PMID 18456568). For everyone else, the lever isn’t the gut — it’s the skincare, trigger management, and (where appropriate) topical or oral rosacea treatment.